Skip to main content

Pharmakotherapie psychiatrischer Notfallsituationen

  • Chapter
Kompendium der Psychiatrischen Pharmakotherapie

Zusammenfassung

Das Spektrum der Pharmakotherapie in der psychiatrischen Notfalltherapie wird ausführlich beschrieben. Das delirante Syndrom nimmt breiteren Raum ein. Die Intoxikationen sind den spezifischen Kapiteln zugeteilt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Al-Qadheeb NS, Balk EM, Fraser GL et al (2014) Randomized ICU trials do not demonstrate an association between interventions that reduce delirium duration and short-term mortality: a systematic review and meta-analysis. Crit Care Med 42: 1442–1454

    Google Scholar 

  • Al-Qadheeb NS, Skrobik Y, Schumaker G et al (2016) Preventing ICU subsyndromal delirium conversion to delirium with low-dose IV haloperidol: a double-blind, placebo-controlled pilot study. Crit Care Med 44(3): 583–591

    Google Scholar 

  • Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41(1): 263–306

    Google Scholar 

  • Barry H, Byrne S, Barrett E et al (2015) Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. B J Psych Bull 39: 19–23

    Google Scholar 

  • Bosanac P, Hollander Y, Castle D (2013) The comparative efficacy of intramuscular antipsychotics for the management of acute agitation. Australas Psychiatry 21(6): 554–562

    Google Scholar 

  • Brydges D, Tibrewal P, Waite S et al (2015) Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation. Aust N Z J Psychiatry 50(4): 386–387

    Google Scholar 

  • Citrome L, Volavka J (2014) The psychopharmacology of violence: making sensible decisions. CNS Spectr 26: 1–8

    Google Scholar 

  • Devlin JW, Michaud CJ, Bullard HM et al (2016) Quetiapine for intensive care unit delirium: the evidence remains weak. Pharmacotherapy 36: e12–e14

    Google Scholar 

  • Drach LM (2014) Symptomatische Psychopharmakotherapie des Delirs im Alter. Psychopharmakotherapie 21(2): 56–63

    Google Scholar 

  • Fleminger S, Greenwood RJ, Oliver DL (2006) Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev (4): CD003299

    Google Scholar 

  • Friedman JI, Soleimani L, McGonigle DP et al (2014) Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trials. Am J Psychiatry 171(2): 151–159

    Google Scholar 

  • Gault TI, Gray SM, Vilke GM, Wilson MP (2012) Are oral medications effective in the management of acute agitation? J Emerg Med 43(5): 854–859

    Google Scholar 

  • Gerresheim G, Schwemmer U (2013) Dexmedetomidin. Anaesthesist 62(8): 661–674

    Google Scholar 

  • Gillies D, Sampson S, Beck A et al (2013) Benzodiazepines for psychosis-induced aggression or agitation. Cochrane Database Syst Rev 9: CD003079

    Google Scholar 

  • Hatta K, Kishi Y, Wada K et al (2014a) Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 71(4): 397–403

    Google Scholar 

  • Hatta K, Kishi Y, Wada K et al (2014b) Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study. Int J Geriatr Psychiatry 29(3):253–62.

    Google Scholar 

  • Huf G, Alexander J, Allen MH, Raveendran NS (2009) Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev (3): CD005146

    Google Scholar 

  • Hüfner H, Sperner-Unterweger B (2014) Delir in der Neurologie. Nervenarzt 85(4): 427–436

    Google Scholar 

  • Jayakody K, Gibson RC, Kumar A, Gunadasa S (2012) Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database Syst Rev 18(4): CD000525

    Google Scholar 

  • Kroll KE, Kroll DS, Pope JV et al (2012) Catatonia in the emergency department. J Emerg Med 43(5): 843–846

    Google Scholar 

  • Lang FU, Lang S, Becker T et al (2015) Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma. Psychopharmacology (Berl) 232: 1–5

    Google Scholar 

  • Lin CC, Huang TL (2013) Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry 54(8): 1210–1214

    Google Scholar 

  • Luchini F, Lattanzi L, Bartolommei N et al (2013) Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. J Nerv Ment Dis 201(1): 36–42

    Google Scholar 

  • MacDonald K, Wilson M, Minassian A et al (2012) A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. J Clin Psychopharmacol 32: 317–322

    Google Scholar 

  • Michaud CJ, Bullard HM, Harris SA et al (2015) Impact of quetiapine treatment on duration of hypoactive delirium in critically ill adults: a retrospective analysis. Pharmacotherapy 35: 731–739

    Google Scholar 

  • Nagel M, Freisberg S, Junghanns K et al (2015) Das maligne neuroleptische Syndrom (MNS) – Eine systematische Übersicht. Fortschr Neurol Psychiatr 83: 373–380

    Google Scholar 

  • Narayanaswamy JC, Tibrewal P, Zutshi A et al (2012) Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry 34(3): 312–316

    Google Scholar 

  • Okumura Y, Hatta K, Wada K et al (2016) Expert opinions on the first-line pharmacological treatment for delirium in Japan: a conjoint analysis. Int Psychogeriatr 28(6): 1041–1050

    Google Scholar 

  • Pollak TA, McCormack R, Peakman M et al (2013) Prevalence of anti-N-methyl-d-aspartate (NMDA) antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med 13: 1–13

    Google Scholar 

  • Powney MJ, Adams CE, Jones H (2012) Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 11: CD009377

    Google Scholar 

  • Prüß H (2013) Neuroimmunologie: Neues zur limbischen Enzephalitis. Akt Neurol 40: 127–136

    Google Scholar 

  • Rolland B, Debien C, Vaiva G (2014) Treatment of agitation in the emergency department: benzodiazepines could be safer than antipsychotics in some cases of insufficient medical data. J Emerg Med 46(6): 830–831

    Google Scholar 

  • Rothberg MB, Herzig SJ, Pekow PS et al (2013) Association between sedating medications and delirium in older inpatients. Am Geriatr Soc. 61(6): 923–930

    Google Scholar 

  • Roy A, Hodgkinson CA, Deluca V et al (2012) Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J Psychiatr Res 46(1): 72–79

    Google Scholar 

  • Rundshagen I (2014) Postoperative kognitive Dysfunktion. Dt Ärztebl 111(8): 119–125

    Google Scholar 

  • Serafim RB, Bozza FA, Soares M et al (2015) Pharmacologic prevention and treatment of delirium in intensive care patients: a systematic review. J Crit Care 30: 799–807

    Google Scholar 

  • Silvestre JS, Prous JR (2007) Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol 29(7): 457–465

    Google Scholar 

  • Steiner J, Walter M, Glanz W et al (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis JAMA Psychiatry 70(3): 271–278

    Google Scholar 

  • Utzerath G, Reske D, Gouzoulis-Mayfrank E (2015) Parenteral applizierte Antipsychotika bei Agitation und Aggression. Fortschr Neurol Psychiatr 83: 665–675

    Google Scholar 

  • Wang HR, Woo YS, Bahk WM (2013) Atypical antipsychotics in the treatment of delirium. Psychiatry Clin Neurosci 67(5): 323–331

    Google Scholar 

  • Wilson MP, Pepper D, Currier GW et al (2012) The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry project Beta Psychopharmacology Workgroup. West J Emerg Med 13(1): 26–34

    Google Scholar 

  • Wilson MP, Minassian A, Bahramzi M et al (2014) Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department. J Emerg Med 46(6): 808–813

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Müller, M., Benkert, O. (2017). Pharmakotherapie psychiatrischer Notfallsituationen. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50333-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50333-1_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50332-4

  • Online ISBN: 978-3-662-50333-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics